<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02039934</url>
  </required_header>
  <id_info>
    <org_study_id>HIT and insulin sensitivity</org_study_id>
    <nct_id>NCT02039934</nct_id>
  </id_info>
  <brief_title>Effect of High-intensity Low-volume Training on Insulin Sensitivity in Type 2 Diabetes</brief_title>
  <acronym>HIT</acronym>
  <official_title>Effect of High-intensity Low-volume Training on Insulin Sensitivity in Patients With Type 2 Diabetes and Healthy Lean Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>German Diabetes Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High intensity interval training is applied for several diseases.&#xD;
&#xD;
      Hypothesis: High intensity interval training improves insulin sensitivity in patients with&#xD;
      type 2 diabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Type 2 diabetes mellitus is a multifactorial metabolic disease that is characterized by&#xD;
      reduced insulin sensitivity and insulin production leading to impaired glucose tolerance.&#xD;
      Overweight and low physical activity are the main risk factors for the development of type 2&#xD;
      diabetes. Increased physical activity has shown to improve insulin sensitivity, hence,&#xD;
      exercise plays a significant role in the prevention and therapy of type 2 diabetes. This&#xD;
      study aims at investigating the acute and chronic effects of high-intensity low-volume&#xD;
      training, that consists of brief bursts of very vigorous exercise separated by recovery&#xD;
      periods, on metabolic function in patients with type 2 diabetes, people at high risk for the&#xD;
      disease and healthy, lean individuals. Study participants take part in 30 min training&#xD;
      session three times a week for a period of 12 weeks. Participants are studied on four&#xD;
      occasions, prior to the intervention, after an acute bout of exercise as well as after 6 and&#xD;
      12 weeks of training in order to assess physical fitness, body composition, insulin&#xD;
      sensitivity, energy metabolism in muscle, adipose tissue inflammation and neurological&#xD;
      function. It is hypothesized that this type of exercise leads to significant improvements in&#xD;
      insulin action and oxidative phosphorylation in muscle&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">August 2018</completion_date>
  <primary_completion_date type="Actual">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of Insulin sensitivity by high intensity interval training</measure>
    <time_frame>2 years</time_frame>
    <description>High intensity interval training leads to significant improvements in insulin action and oxidative phosphorylation in skeletal muscle.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>high intensity interval training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High intensity interval training</intervention_name>
    <description>The intervention consists of 30 minute sessions of high-intensity interval training on a bicycle ergometer three times per week.&#xD;
Training program: After 5 minutes of warm-up the subject cycles for 10 intervals of 60 s. at 90 % maximum effort separated 60 s at 20% maximum effort, based on a previously performed spiroergometry, followed by 5 minutes of cool-down.</description>
    <arm_group_label>high intensity interval training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Men and women&#xD;
&#xD;
          -  Age: 30 - 65 years&#xD;
&#xD;
          -  Typ-2-Diabetes (BMI &gt; 25 kg/m²)&#xD;
&#xD;
          -  Increased risk for diabetes (BMI &gt;25 kg/m²)&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Acute Infection within the last 2 weeks prior to the intervention&#xD;
&#xD;
          -  Autoimmune diseases and immune suppressive diseases (Leukocytes &lt; 5000/μl)&#xD;
&#xD;
          -  Intake of immunomodulating drugs (Glucocorticoids, Antihistamine, ASS)&#xD;
&#xD;
          -  Pregnancy, Breastfeeding, Menstruation&#xD;
&#xD;
          -  Kidney insufficiency (Creatinine &gt; 1,5 mg/dl)&#xD;
&#xD;
          -  Cardiovascular diseases&#xD;
&#xD;
          -  Anemia (Hb &lt; 12g/l), disorders of wound healing or blood clotting&#xD;
&#xD;
          -  Participation in another study within the last 2 months before the investigation&#xD;
&#xD;
          -  Metallic or magnetic items on or in the body&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Thyroid dysfunction&#xD;
&#xD;
          -  Intake of glitazones or insulin therapy&#xD;
&#xD;
          -  Smoking (Non-smoking since &gt; 1 year), alcohol consumption (Men &gt; 30 g/d, Women &gt;&#xD;
             20g/d) or illegal drugs&#xD;
&#xD;
          -  Psychiatric disorders&#xD;
&#xD;
          -  Risk for/or manifest AIDS (HIV) or Hepatitis B or C&#xD;
&#xD;
          -  Night shift working&#xD;
&#xD;
          -  Hypersensitivity to local anesthetics&#xD;
&#xD;
          -  Cancer disease&#xD;
&#xD;
          -  Lung diseases&#xD;
&#xD;
          -  Systematic endurance training (&gt;1x per week &gt; 60min.)&#xD;
&#xD;
          -  Maximal oxygen consumption (VO2 max) &lt;20ml/min/kg&#xD;
&#xD;
          -  Orthopedic disorders&#xD;
&#xD;
          -  Musculoskeletal diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia Szendrödi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Diabetes Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Deutsches Diabetes Zentrum</name>
      <address>
        <city>Düsseldorf</city>
        <state>Nordrhein-Westfalen</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 7, 2012</study_first_submitted>
  <study_first_submitted_qc>January 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2014</study_first_posted>
  <last_update_submitted>November 21, 2020</last_update_submitted>
  <last_update_submitted_qc>November 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Diabetes Center</investigator_affiliation>
    <investigator_full_name>julia szendrödi</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>type 2 diabetes</keyword>
  <keyword>exercise intervention</keyword>
  <keyword>high intensity interval training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

